Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06393634 · ClinicalTrials.gov registry record · Early Phase 1
Comparing Direct and Indirect Detection Methods of Multiple Routes of Testosterone Administration
A Early Phase 1 study, sponsored by Sports Medicine Research and Testing Laboratory.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 14
- Enrollment target
NCT06393634: Completed Early Phase 1 study, sponsored by Sports Medicine Research and Testing Laboratory.
NCT06393634 is a Early Phase 1 study that has completed, run by Sports Medicine Research and Testing Laboratory. The registered enrollment target is 14 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06393634, a Early Phase 1 study, has completed, sponsored by Sports Medicine Research and Testing Laboratory.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
Testosterone abuse is extremely prevalent in athletes globally and especially in the United States professional sporting leagues
Primary Outcome
Changes in urinary testosterone/epitestosterone ratio after administration of testosterone in injection, oral and cream
Interventions
- DRUG Testosterone gel
- DRUG Testosterone injection
- DRUG Testosterone Oral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2024-11-27 |
| Est. Completion | 2024-11-27 |
| Phase | Early Phase 1 |
What the finished NCT06393634 record still lists
NCT06393634 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 3 interventions - of which Testosterone gel is the first listed.
NCT06393634 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06393634 about?
NCT06393634 is a clinical study titled "Comparing Direct and Indirect Detection Methods of Multiple Routes of Testosterone Administration". Testosterone abuse is extremely prevalent in athletes globally and especially in the United States professional sporting leagues
What is the current status of trial NCT06393634?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 14 participants. The study started on 2024-11-27. Estimated completion is 2024-11-27.
What interventions are being tested in trial NCT06393634?
The interventions under investigation include: Testosterone gel (DRUG), Testosterone injection (DRUG), Testosterone Oral (DRUG).
Who is sponsoring clinical trial NCT06393634?
This trial is sponsored by Sports Medicine Research and Testing Laboratory, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06393634's enrollment target sits among peer trials
14 1474th of 2000 higher than 498 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy